Hodgkin Lymphoma Version 1.2017, NCCN Clinical Practice Guidelines in Oncology.


Journal Article

This portion of the NCCN Guidelines for Hodgkin lymphoma (HL) focuses on the management of classical HL. Current management of classical HL involves initial treatment with chemotherapy or combined modality therapy followed by restaging with PET/CT to assess treatment response using the Deauville criteria (5-point scale). The introduction of less toxic and more effective regimens has significantly advanced HL cure rates. However, long-term follow-up after completion of treatment is essential to determine potential long-term effects.

Full Text

Duke Authors

Cited Authors

  • Hoppe, RT; Advani, RH; Ai, WZ; Ambinder, RF; Aoun, P; Bello, CM; Benitez, CM; Bernat, K; Bierman, PJ; Blum, KA; Chen, R; Dabaja, B; Forero, A; Gordon, LI; Hernandez-Ilizaliturri, FJ; Hochberg, EP; Huang, J; Johnston, PB; Kaminski, MS; Kenkre, VP; Khan, N; Maloney, DG; Mauch, PM; Metzger, M; Moore, JO; Morgan, D; Moskowitz, CH; Mulroney, C; Poppe, M; Rabinovitch, R; Seropian, S; Smith, M; Winter, JN; Yahalom, J; Burns, J; Ogba, N; Sundar, H

Published Date

  • May 2017

Published In

Volume / Issue

  • 15 / 5

Start / End Page

  • 608 - 638

PubMed ID

  • 28476741

Pubmed Central ID

  • 28476741

Electronic International Standard Serial Number (EISSN)

  • 1540-1413


  • eng

Conference Location

  • United States